1,264
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Synergistic in vitro activity of sodium houttuyfonate with fluconazole against clinical Candida albicans strains under planktonic growing conditions

, , , , &
Pages 355-359 | Received 11 Mar 2016, Accepted 14 Sep 2016, Published online: 08 Dec 2016

References

  • Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard Document M27-A3, 3rd ed. CLSI: Wayne, PA: CLSI.
  • de Repentigny L, Lewandowski D, Jolicoeur P. 2004. Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin Microbiol Rev. 17:729–759.
  • Flowers SA, Colón B, Whaley SG, Schuler MA, Rogers PD. 2015. Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans. Antimicrob Agents Chemother. 59:450–460.
  • Guo XL, Leng P, Yang Y, Yu LG, Lou HX. 2008. Plagiochin E, a botanic-derived phenolic compound, reverses fungal resistance to fluconazole relating to the efflux pump. J Appl Microbiol. 104:831–838.
  • Holmes AR, Lin YH, Niimi K, Lamping E, Keniya M, Niimi M, Tanabe K, Monk BC, Cannon RD. 2008. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Antimicrob Agents Chemother. 52:3851–3862.
  • Huang W, Duan Q, Li F, Shao J, Cheng H, Wu D. 2015. Sodium houttuyfonate and EDTA-Na2 in combination effectively inhibits Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans in vitro and in vivo. Bioorg Med Chem Lett. 25:142–147.
  • Letscher-Bru V, Obszynski C, Samsoen M, Sabou M, Waller J, Candolfi E. 2013. Antifungal activity of sodium bicarbonate against fungal agents causing superficial infections. Mycopathologia. 175:153–158.
  • Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 25:402–408.
  • Mio T, Adachi-Shimizu M, Tachibana Y, Tabuchi H, Inoue SB, Yabe T, Yamada-Okabe T, Arisawa M, Watanabe T, Yamada-Okabe H. 1997. Cloning of the Candida albicans homolog of Saccharomyces cerevisiae GSC1/FKS1 and its involvement in beta-1,3-glucan synthesis. J Bacteriol. 179:4096–4105.
  • Miyakawa Y, Mabuchi T, Fukazawa Y. 1993. New method for detection of Candida albicans in human blood by polymerase chain reaction. J Clin Microbiol. 31:3344–3347.
  • Nett J, Lincoln L, Marchillo K, Massey R, Holoyda K, Hoff B, VanHandel M, Andes D. 2007. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother. 51:510–520.
  • Niimi M, Niimi K, Takano Y, Holmes AR, Fischer FJ, Uehara Y, Cannon RD. 2004. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance. J Antimicrob Chemother. 54:999–1006.
  • Nobile CJ, Nett JE, Hernday AD, Homann OR, Deneault JS, Nantel A, Andes DR, Johnson AD, Mitchell AP. 2009. Biofilm matrix regulation by Candida albicans Zap1. PLoS Biol. 7:e1000133.
  • Odds F. 2003. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 52:1.
  • Padmavathi AR, Bakkiyaraj D, Thajuddin N, Pandian SK. 2015. Effect of 2, 4-di-tert-butylphenol on growth and biofilm formation by an opportunistic fungus Candida albicans. Biofouling. 31:565–574.
  • Poulain D. 2013. Candida albicans, plasticity and pathogenesis. Crit Rev Microbiol. 41:208–217.
  • Prasad R, Rawal MK. 2014. Efflux pump proteins in antifungal resistance. Front Pharmacol. 5:202.
  • Quan H, Cao YY, Xu Z, Zhao JX, Gao PH, Qin XF, Jiang YY. 2006. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Antimicrob Agents Chemother. 50:1096–1099.
  • Sardi J, Scorzoni L, Bernardi T, Fusco-Almeida A, Giannini MM. 2013. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 62:10–24.
  • Shao J, Cheng H, Wang C, Wang Y. 2012. A phytoanticipin derivative, sodium houttuyfonate, induces in vitro synergistic effects with levofloxacin against biofilm formation by Pseudomonas aeruginosa. Molecules. 17:11242–11254.
  • Shao J, Cheng HJ, Wu DQ, Wang CZ, Zhu LL, Sun ZX, Duan QJ, Huang WF, Huang JL. 2013. Antimicrobial effect of sodium houttuyfonate on Staphylococcus epidermidis and Candida albicans biofilms. J Tradit Chin Med. 33:798–803.
  • Shao J, Wang TM, Yan YY, Shi GX, Cheng HJ, Wu DQ, Wang CZ. 2014. Matrine reduces yeast-to-hypha transition and resistance of a fluconazole-resistant strain of Candida albicans. J Appl Microbiol. 117:618–626.
  • Sobel JD. 2007. Vulvovaginal candidosis. Lancet. 369:1961–1971.
  • Taff HT, Nett JE, Zarnowski R, Ross KM, Sanchez H, Cain MT, Hamaker J, Mitchell AP, Andes DR. 2012. A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog. 8:e1002848.
  • Tobudic S, Kratzer C, Lassnigg A, Presterl E. 2012. Antifungal susceptibility of Candida albicans in biofilms. Mycoses. 55:199–204.
  • Xiang MJ, Liu JY, Ni PH, Wang S, Shi C, Wei B, Ni YX, Ge HL. 2013. Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans. FEMS Yeast Res. 13:386–393.
  • Zarnowski R, Westler WM, Lacmbouh GA, Marita JM, Bothe JR, Bernhardt J, Sahraoui ALH, Fontaine J, Sanchez H, Hatfield RD. 2014. Novel entries in a fungal biofilm matrix encyclopedia. mBio. 5:e01333–e01314.
  • Zavrel M, White TC. 2015. Medically important fungi respond to azole drugs: an update. Future Microbiol. 10:1355–1373.
  • Zhou Y, Wang G, Li Y, Liu Y, Song Y, Zheng W, Zhang N, Hu X, Yan S, Jia J. 2012. In vitro interactions between aspirin and amphotericin B against planktonic cells and biofilm cells of Candida albicans and C. parapsilosis. Antimicrob Agents Chemother. 56:3250–3260.